Related Experiment Videos
[Damage to condoms caused by vaginally administered drug]
R H Meyboom1, J S Havinga, C J Lastdrager
1Stichting Landelijke Registratie Evaluatie Bijwerkingen, Tilburg.
Nederlands Tijdschrift Voor Geneeskunde
|August 5, 1995
Summary
Miconazole nitrate vaginal capsules can damage condoms, increasing pregnancy risk. Patients using vaginal medications should be aware of potential contraceptive failure and increased STI transmission risks.
Area of Science:
- Pharmacology
- Materials Science
Background:
- Vaginal candidiasis is commonly treated with antifungal medications.
- Contraceptive methods like condoms and diaphragms are crucial for family planning and STI prevention.
Observation:
- A case of unintended pregnancy occurred in a patient using miconazole nitrate vaginal capsules.
- In vitro testing revealed that miconazole nitrate vaginal capsules, but not the cream formulation, degraded rubber condoms.
Findings:
- Miconazole nitrate vaginal capsules (Gyno-Daktarin 3 and Gyno-Daktarin I) at 400 mg and 1200 mg concentrations demonstrated a damaging effect on rubber condoms.
- The vaginal cream formulation of miconazole nitrate (20 mg/g) did not show similar condom-damaging properties.
- Fatty excipients in the vaginal capsules may contribute to the degradation of latex condoms.
Implications:
- Patients using miconazole nitrate vaginal capsules should be informed about the potential for condom or diaphragm failure.
- This interaction necessitates discussing alternative contraceptive methods or additional precautions with healthcare providers.
- The findings highlight the importance of considering the physical compatibility of vaginal medications with barrier contraceptives to prevent unintended pregnancies and STI transmission.
Keywords:
Bacterial And Fungal DiseasesBarrier Methods--standardsCandidiasisCondom--standardsContraceptionContraception FailureContraceptive Methods--standardsContraceptive UsageDeveloped CountriesDiseasesEuropeFamily PlanningInfectionsNetherlandsOrganization And AdministrationQuality ControlTreatmentVaginal AbnormalitiesWestern Europe